Back
Harmony Biosciences Holdings Vs. Arrowhead Pharmaceuticals Industry Stock Comparison
Buy
80
HRMY
Harmony Biosciences Holdings
Last Price:
35.59
Seasonality Move:
5.48%
Sell
37
ARWR
Arrowhead Pharmaceuticals
Last Price:
22.24
Seasonality Move:
0.24%
Buy
80
Harmony Biosciences Holdings (HRMY)
is a Buy
Is Harmony Biosciences Holdings a Buy, Sell or Hold?
- The current Harmony Biosciences Holdings [HRMY] share price is $35.59. The Score for HRMY is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- HRMY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy, Sell or Hold?
- The current Arrowhead Pharmaceuticals [ARWR] share price is $22.22. The Score for ARWR is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ARWR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HRMY Stock Price Chart
What is Harmony Biosciences Holdings's stock price today?
-
The Harmony Biosciences Holdings share price today is $35.59
The current trend is moderately bullish and HRMY is experiencing slight buying pressure.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals's stock price today?
-
The Arrowhead Pharmaceuticals share price today is $22.22
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARWR is experiencing selling pressure, which indicates risk of future bearish movement.
HRMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.63 | Buy |
| Relative Strength Index (14 RSI): | 54.21 | Buy |
| Chaikin Money Flow: | 9209 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.56 - 36.42) | Buy |
| Bollinger Bands (100): | (29.45 - 34.31) | Buy |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.69 | Sell |
| Relative Strength Index (14 RSI): | 36.99 | Sell |
| Chaikin Money Flow: | -679179 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.88 - 25.08) | Sell |
| Bollinger Bands (100): | (23.05 - 26.91) | Sell |
HRMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.8 | Sell |
| 20-day SMA: | 35.55 | Buy |
| 50-day SMA: | 33.9 | Buy |
| 200-day SMA: | 31.81 | Buy |
| 8-day EMA: | 35.8 | Sell |
| 20-day EMA: | 35.37 | Buy |
| 50-day EMA: | 34.05 | Buy |
| 200-day EMA: | 32.6 | Buy |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.52 | Sell |
| 20-day SMA: | 23.57 | Sell |
| 50-day SMA: | 25.73 | Sell |
| 200-day SMA: | 27.51 | Sell |
| 8-day EMA: | 23.39 | Sell |
| 20-day EMA: | 24.03 | Sell |
| 50-day EMA: | 24.95 | Sell |
| 200-day EMA: | 26.97 | Sell |
Harmony Biosciences Holdings Earnings Growth & HRMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.24 per share, a decrease this year of $0.14 per share, and an increase next year of $2.29 per share.
Arrowhead Pharmaceuticals Earnings Growth & ARWR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.51 per share, an increase next quarter of $0.05 per share, a decrease this year of $3.09 per share, and an increase next year of $0.08 per share.
Harmony Biosciences Holdings Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||